Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Understand the usual disbursement timing after refinance approval and actions that can speed or delay access to funds.
21,084 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Investors brace for MSCI’s late-June decision on Indonesia’s market status, with potential outflows tied to a downgra...
Nearly $7.8 trillion sits in U.S. money market funds, awaiting a catalyst. As liquidity rotates back into risk assets...
A security advisory from Ethereum L2 Taiko warns users to pull funds from Taiko-linked bridges after a state verifica...
A straightforward, long-term approach: invest $1,000 in three broad Vanguard ETFs to build a solid, diversified core....
A high-yield AI-focused ETF sounds tempting, but a big payout can hide risks. This article breaks down how the divide...
In a volatile market, a straightforward approach is gaining traction: carve out an income sleeve that pays a steady $...
A viral online persona hid a troubling reality: a calculated scheme built on a bogus cancer crisis. Learn the red fla...
Oil markets are volatile and opportunity-filled. This guide explains why here's prices surging right and shows practi...
As inflation cools and rates hold, retirees are increasingly turning to preferred stock ETFs to secure steady, bond-l...
Two popular tech ETFs sit on opposite ends of the spectrum: a broad technology exposure semiconductor approach with V...
Curious about private access to AI giants? This guide explains how pre-IPO shares anthropic openai work, the real cha...